Acrivon Therapeutics, Inc. Common Stock (ACRV)

USD 1.5

(-8.84%)

Total Liabilities Summary of Acrivon Therapeutics, Inc. Common Stock

  • Acrivon Therapeutics, Inc. Common Stock's latest annual total liabilities in 2023 was 17.07 Million USD , up 58.78% from previous year.
  • Acrivon Therapeutics, Inc. Common Stock's latest quarterly total liabilities in 2024 Q2 was 14.52 Million USD , up 15.83% from previous quarter.
  • Acrivon Therapeutics, Inc. Common Stock reported annual total liabilities of 10.75 Million USD in 2022, down -91.76% from previous year.
  • Acrivon Therapeutics, Inc. Common Stock reported annual total liabilities of 130.39 Million USD in 2021, up 1130.38% from previous year.
  • Acrivon Therapeutics, Inc. Common Stock reported quarterly total liabilities of 12.54 Million USD for 2024 Q1, down -26.53% from previous quarter.
  • Acrivon Therapeutics, Inc. Common Stock reported quarterly total liabilities of 17.07 Million USD for 2023 Q4, up 31.89% from previous quarter.

Annual Total Liabilities Chart of Acrivon Therapeutics, Inc. Common Stock (2023 - 2020)

Historical Annual Total Liabilities of Acrivon Therapeutics, Inc. Common Stock (2023 - 2020)

Year Total Liabilities Total Liabilities Growth
2023 17.07 Million USD 58.78%
2022 10.75 Million USD -91.76%
2021 130.39 Million USD 1130.38%
2020 10.59 Million USD 0.0%

Peer Total Liabilities Comparison of Acrivon Therapeutics, Inc. Common Stock

Name Total Liabilities Total Liabilities Difference
AbCellera Biologics Inc. 335.77 Million USD 94.916%
Alkermes plc 933.53 Million USD 98.171%
Agenus Inc. 462.29 Million USD 96.308%
Alnylam Pharmaceuticals, Inc. 4.05 Billion USD 99.579%
Aptorum Group Limited 5.25 Million USD -224.726%
Ardelyx, Inc. 130.76 Million USD 86.946%
Arrowhead Pharmaceuticals, Inc. 478.39 Million USD 96.432%
Bicycle Therapeutics plc 224.41 Million USD 92.393%
BioXcel Therapeutics, Inc. 130.21 Million USD 86.89%
ChromaDex Corporation 26.5 Million USD 35.604%
Chimerix, Inc. 19.74 Million USD 13.548%
Corbus Pharmaceuticals Holdings, Inc. 35.17 Million USD 51.474%
Caribou Biosciences, Inc. 72.56 Million USD 76.477%
CRISPR Therapeutics AG 346.76 Million USD 95.077%
Precision BioSciences, Inc. 140.92 Million USD 87.887%
Dyadic International, Inc. 2.34 Million USD -629.284%
Eton Pharmaceuticals, Inc. 16.26 Million USD -4.962%
Fortress Biotech, Inc. 165.93 Million USD 89.713%
Lantern Pharma Inc. 2.73 Million USD -523.065%
HOOKIPA Pharma Inc. 71.48 Million USD 76.119%
Inhibikase Therapeutics, Inc. 3.52 Million USD -383.744%
Incyte Corporation 1.59 Billion USD 98.928%
IO Biotech, Inc. 17.55 Million USD 2.768%
Jaguar Health, Inc. 45.86 Million USD 62.783%
Novavax, Inc. 2.57 Billion USD 99.336%
Janux Therapeutics, Inc. 36.05 Million USD 52.66%
Opthea Limited 264.6 Million USD 93.549%
Ligand Pharmaceuticals Incorporated 130.7 Million USD 86.94%
ContextLogic Inc. 206 Million USD 91.714%
MiMedx Group, Inc. 96.33 Million USD 82.28%
Pyxis Oncology, Inc. 48.02 Million USD 64.454%
TransCode Therapeutics, Inc. 3.52 Million USD -383.722%
NextCure, Inc. 14.99 Million USD -13.823%
Ocuphire Pharma, Inc. 4.04 Million USD -322.316%
Oncternal Therapeutics, Inc. 6.67 Million USD -155.654%
Outlook Therapeutics, Inc. 46.73 Million USD 63.478%
Vaxcyte, Inc. 167.44 Million USD 89.806%
PDS Biotechnology Corporation 33.25 Million USD 48.676%
Madrigal Pharmaceuticals, Inc. 235.21 Million USD 92.743%
Pharming Group N.V. 244.07 Million USD 93.006%
Pieris Pharmaceuticals, Inc. 11.92 Million USD -43.181%
Avidity Biosciences, Inc. 127.79 Million USD 86.642%
Reviva Pharmaceuticals Holdings, Inc. 6.6 Million USD -158.351%
Reviva Pharmaceuticals Holdings, Inc. 6.6 Million USD -158.351%
Sangamo Therapeutics, Inc. 82.43 Million USD 79.292%
Sol-Gel Technologies Ltd. 6.64 Million USD -156.962%
Acelyrin, Inc. 86.35 Million USD 80.232%
Salarius Pharmaceuticals, Inc. 1.29 Million USD -1213.844%
SELLAS Life Sciences Group, Inc. 14.37 Million USD -18.715%
Summit Therapeutics Inc. 125.25 Million USD 86.372%
Sensei Biotherapeutics, Inc. 9.47 Million USD -80.082%
Senti Biosciences, Inc. 52.57 Million USD 67.53%
Stoke Therapeutics, Inc. 68.77 Million USD 75.181%
Syros Pharmaceuticals, Inc. 151.51 Million USD 88.734%
Alaunos Therapeutics, Inc. 1.95 Million USD -772.699%
Telomir Pharmaceuticals, Inc. Common Stock 1.33 Million USD -1178.112%
Entrada Therapeutics, Inc. 226.83 Million USD 92.475%
VistaGen Therapeutics, Inc. 9.36 Million USD -82.236%
Wave Life Sciences Ltd. 227.44 Million USD 92.495%
Sorrento Therapeutics, Inc. 494.5 Million USD 96.548%
TRACON Pharmaceuticals, Inc. 10.91 Million USD -56.405%
Barinthus Biotherapeutics plc 27.51 Million USD 37.952%
Psyence Biomedical Ltd. 12.1 Million USD -41.02%
Phathom Pharmaceuticals, Inc. 486.6 Million USD 96.492%
Immix Biopharma, Inc. 3.72 Million USD -358.651%
Keros Therapeutics, Inc. 37.81 Million USD 54.856%
MEI Pharma, Inc. 8.35 Million USD -104.309%
Windtree Therapeutics, Inc. 29.01 Million USD 41.168%
Xeris Biopharma Holdings, Inc. 347.58 Million USD 95.089%
Rigel Pharmaceuticals, Inc. 145.86 Million USD 88.298%
Fortress Biotech, Inc. 165.93 Million USD 89.713%
Precigen, Inc. 41.64 Million USD 59.01%
Clearside Biomedical, Inc. 49.93 Million USD 65.812%
AlloVir, Inc. 45.01 Million USD 62.079%
C4 Therapeutics, Inc. 130.33 Million USD 86.903%
Fate Therapeutics, Inc. 137.8 Million USD 87.612%
ImmuCell Corporation 18.81 Million USD 9.275%
IDEAYA Biosciences, Inc. 28.22 Million USD 39.524%
Onconetix, Inc. 23.18 Million USD 26.362%
PureTech Health plc 125.58 Million USD 86.407%
VYNE Therapeutics Inc. 8.95 Million USD -90.726%
Elevation Oncology, Inc. 34.28 Million USD 50.207%
Kintara Therapeutics, Inc. 2.44 Million USD -598.16%
Seer, Inc. 39.36 Million USD 56.637%
Verrica Pharmaceuticals Inc. 61.83 Million USD 72.394%
Innoviva, Inc. 568.55 Million USD 96.998%
Aadi Bioscience, Inc. 27.22 Million USD 37.307%
ESSA Pharma Inc. 3.49 Million USD -388.402%
GlycoMimetics, Inc. 6.9 Million USD -147.317%
GT Biopharma, Inc. 6.63 Million USD -157.35%
Inhibrx Biosciences, Inc. 264.39 Million USD 93.544%
Akebia Therapeutics, Inc. 272.28 Million USD 93.731%
Catalyst Pharmaceuticals, Inc. 84.02 Million USD 79.685%
Longboard Pharmaceuticals, Inc. 9.77 Million USD -74.647%
Orchestra BioMed Holdings, Inc. 27.16 Million USD 37.171%
Alzamend Neuro, Inc. 3.22 Million USD -429.175%
Rocket Pharmaceuticals, Inc. 73.76 Million USD 76.86%
Aptose Biosciences Inc. 15.8 Million USD -7.979%
ZyVersa Therapeutics, Inc. 11.03 Million USD -54.624%
Soligenix, Inc. 7.27 Million USD -134.642%
Century Therapeutics, Inc. 175.94 Million USD 90.298%
Kura Oncology, Inc. 51.66 Million USD 66.958%
TScan Therapeutics, Inc. 121.28 Million USD 85.925%
Intensity Therapeutics, Inc. 4.13 Million USD -313.017%
Ocean Biomedical, Inc. 6.61 Million USD -158.095%
CytomX Therapeutics, Inc. 252.59 Million USD 93.242%
Autolus Therapeutics plc 263.9 Million USD 93.532%
Mineralys Therapeutics, Inc. 10.48 Million USD -62.851%
EyePoint Pharmaceuticals, Inc. 88.86 Million USD 80.79%
Eterna Therapeutics Inc. 46.89 Million USD 63.603%
Adaptive Biotechnologies Corporation 352.85 Million USD 95.162%
GRI Bio, Inc. 2.69 Million USD -532.925%
Xenetic Biosciences, Inc. 809.58 Thousand USD -2008.488%
Tenaya Therapeutics, Inc. 31.09 Million USD 45.097%
IGM Biosciences, Inc. 220.17 Million USD 92.247%
INmune Bio, Inc. 18.86 Million USD 9.501%
Heron Therapeutics, Inc. 256.47 Million USD 93.344%
SAB Biotherapeutics, Inc. 26.64 Million USD 35.928%
Pasithea Therapeutics Corp. 2.71 Million USD -527.942%
Entero Therapeutics, Inc. 3.28 Million USD -420.385%
Milestone Pharmaceuticals Inc. 58.45 Million USD 70.798%
X4 Pharmaceuticals, Inc. 96.15 Million USD 82.248%
Atara Biotherapeutics, Inc. 264.73 Million USD 93.552%
Coherus BioSciences, Inc. 823.02 Million USD 97.926%
Verastem, Inc. 71.18 Million USD 76.02%
Abeona Therapeutics Inc. 49.17 Million USD 65.288%
Pliant Therapeutics, Inc. 38.57 Million USD 55.752%
Tonix Pharmaceuticals Holding Corp. 48.93 Million USD 65.115%
Histogen Inc. 5.69 Million USD -199.631%
Aprea Therapeutics, Inc. 4.38 Million USD -289.228%
Surrozen, Inc. 8.14 Million USD -109.576%
Organovo Holdings, Inc. 2.74 Million USD -521.179%
Lixte Biotechnology Holdings, Inc. 313.85 Thousand USD -5338.765%
Ovid Therapeutics Inc. 56.22 Million USD 69.642%
Panbela Therapeutics, Inc. 16.51 Million USD -3.379%
CASI Pharmaceuticals, Inc. 51.1 Million USD 66.597%
Cadrenal Therapeutics, Inc. Common Stock 826.87 Thousand USD -1964.399%
Centessa Pharmaceuticals plc 126.72 Million USD 86.53%
Hepion Pharmaceuticals, Inc. 10.81 Million USD -57.857%
Arcturus Therapeutics Holdings Inc. 150.88 Million USD 88.687%
BioRestorative Therapies, Inc. 2.6 Million USD -554.689%
Apollomics, Inc. 14.15 Million USD -20.61%
Amarin Corporation plc 279.58 Million USD 93.895%
Mesoblast Limited 188.79 Million USD 90.959%
Turnstone Biologics Corp. 14.14 Million USD -20.653%
Kymera Therapeutics, Inc. 180.78 Million USD 90.558%
Synaptogenix, Inc. 5.52 Million USD -208.71%
Tiziana Life Sciences Ltd 6.64 Million USD -156.769%
Aurinia Pharmaceuticals Inc. 170.1 Million USD 89.965%
BriaCell Therapeutics Corp. 8.55 Million USD -99.481%
Monopar Therapeutics Inc. 1.75 Million USD -871.325%
Exelixis, Inc. 678.44 Million USD 97.484%
Better Therapeutics, Inc. 23.84 Million USD 28.404%
Nurix Therapeutics, Inc. 164.04 Million USD 89.594%
Apellis Pharmaceuticals, Inc. 594.2 Million USD 97.127%
NLS Pharmaceutics AG 10.68 Million USD -59.828%
Dermata Therapeutics, Inc. 1.62 Million USD -951.357%
Aridis Pharmaceuticals, Inc. 38.92 Million USD 56.149%
Gritstone bio, Inc. 125.91 Million USD 86.444%
Jasper Therapeutics, Inc. 14.67 Million USD -16.312%
TNF Pharmaceuticals, Inc. 5.08 Million USD -235.454%
Avid Bioservices, Inc. 275.66 Million USD 93.808%
Insmed Incorporated 1.66 Billion USD 98.973%
Virpax Pharmaceuticals, Inc. 7.69 Million USD -121.86%
MediWound Ltd. 27.18 Million USD 37.213%
OmniAb, Inc. 87.4 Million USD 80.469%
Alector, Inc. 487.66 Million USD 96.5%
Seres Therapeutics, Inc. 403.45 Million USD 95.769%
Checkpoint Therapeutics, Inc. 18.42 Million USD 7.354%
Viracta Therapeutics, Inc. 38.37 Million USD 55.516%
Zai Lab Limited 240.17 Million USD 92.893%
Revance Therapeutics, Inc. 630.05 Million USD 97.291%
Aura Biosciences, Inc. 29.22 Million USD 41.595%
Lyell Immunopharma, Inc. 95.07 Million USD 82.046%
Immunic, Inc. 25.36 Million USD 32.711%
Tarsus Pharmaceuticals, Inc. 69.23 Million USD 75.345%
Veracyte, Inc. 93.71 Million USD 81.786%
InMed Pharmaceuticals Inc. 2.61 Million USD -552.355%
FibroGen, Inc. 585.72 Million USD 97.086%
SeaStar Medical Holding Corporation 17.38 Million USD 1.801%
Adial Pharmaceuticals, Inc. 653.07 Thousand USD -2513.785%
Sonnet BioTherapeutics Holdings, Inc. 5.65 Million USD -201.832%
Jazz Pharmaceuticals plc 7.65 Billion USD 99.777%
Cyclacel Pharmaceuticals, Inc. 8.19 Million USD -108.222%
Amylyx Pharmaceuticals, Inc. 84.02 Million USD 79.684%
TG Therapeutics, Inc. 169.08 Million USD 89.904%
Galecto, Inc. 5.89 Million USD -189.518%
Calithera Biosciences, Inc. 8.28 Million USD -106.06%
Fortrea Holdings Inc. 2.61 Billion USD 99.348%
KalVista Pharmaceuticals, Inc. 28.82 Million USD 40.774%
Aptevo Therapeutics Inc. 12.62 Million USD -35.251%
XBiotech Inc. 8.39 Million USD -103.287%
Jasper Therapeutics, Inc. 14.67 Million USD -16.312%
Lyra Therapeutics, Inc. 53.18 Million USD 67.901%
Foghorn Therapeutics Inc. 363.1 Million USD 95.299%
Y-mAbs Therapeutics, Inc. 26.88 Million USD 36.505%
Theravance Biopharma, Inc. 169 Million USD 89.9%
Ultragenyx Pharmaceutical Inc. 1.21 Billion USD 98.596%
Metagenomi, Inc. Common Stock 500.42 Million USD 96.589%
Vaxxinity, Inc. 30.94 Million USD 44.836%
BioCryst Pharmaceuticals, Inc. 972.48 Million USD 98.245%
Gain Therapeutics, Inc. 6.03 Million USD -183.033%
Cartesian Therapeutics, Inc. 745.23 Million USD 97.709%
NexImmune, Inc. 5.08 Million USD -235.744%
Creative Medical Technology Holdings, Inc. 371.39 Thousand USD -4496.197%
Marker Therapeutics, Inc. 3.07 Million USD -455.149%
Regeneron Pharmaceuticals, Inc. 7.1 Billion USD 99.76%
Chemomab Therapeutics Ltd. 5.15 Million USD -231.197%
Scopus BioPharma Inc. 7.45 Million USD -128.991%
RAPT Therapeutics, Inc. 26.29 Million USD 35.08%
Ainos, Inc. 7.39 Million USD -130.856%
Pluri Inc. 34.11 Million USD 49.959%
Prothena Corporation plc 135.01 Million USD 87.357%
Adaptimmune Therapeutics plc 243.1 Million USD 92.978%
Celularity Inc. 102.92 Million USD 83.416%
Rallybio Corporation 9.43 Million USD -80.903%
Cue Biopharma, Inc. 24.44 Million USD 30.17%
MeiraGTx Holdings plc 319.99 Million USD 94.665%
Omeros Corporation 403.25 Million USD 95.767%
Humacyte, Inc. 114.67 Million USD 85.115%
Immunocore Holdings plc 228.15 Million USD 92.518%
Cocrystal Pharma, Inc. 4.87 Million USD -250.154%
Cidara Therapeutics, Inc. 76.74 Million USD 77.756%
Blueprint Medicines Corporation 918.64 Million USD 98.142%
CalciMedica, Inc. 4.02 Million USD -323.784%
Cabaletta Bio, Inc. 17.45 Million USD 2.189%
Marinus Pharmaceuticals, Inc. 154.14 Million USD 88.926%
Scholar Rock Holding Corporation 85.81 Million USD 80.109%
Sana Biotechnology, Inc. 277.79 Million USD 93.855%
Pulmatrix, Inc. 15.96 Million USD -6.935%
Elicio Therapeutics, Inc. 15.77 Million USD -8.223%
Vigil Neuroscience, Inc. 24.6 Million USD 30.627%
Intellia Therapeutics, Inc. 250.8 Million USD 93.194%
Adlai Nortye Ltd. American Depositary Shares 50.78 Million USD 66.388%
Cytokinetics, Incorporated 1.21 Billion USD 98.59%
Eloxx Pharmaceuticals, Inc. 31.78 Million USD 46.292%
Nutriband Inc. 1.07 Million USD -1482.139%
Protara Therapeutics, Inc. 10.63 Million USD -60.538%
Vor Biopharma Inc. 59.1 Million USD 71.119%
Roivant Sciences Ltd. 773.95 Million USD 97.794%
Evogene Ltd. 17.99 Million USD 5.114%
ProKidney Corp. 29.21 Million USD 41.573%
Applied Therapeutics, Inc. 71.97 Million USD 76.285%
Hoth Therapeutics, Inc. 704.98 Thousand USD -2321.335%
BridgeBio Pharma, Inc. 1.88 Billion USD 99.096%
CorMedix Inc. 11.91 Million USD -43.234%
BioLineRx Ltd. 50.7 Million USD 66.333%
Tango Therapeutics, Inc. 149.45 Million USD 88.579%
Galectin Therapeutics Inc. 88.44 Million USD 80.699%
Atai Life Sciences N.V. 49.16 Million USD 65.278%
Renovaro Biosciences Inc. 31.15 Million USD 45.205%
Aerovate Therapeutics, Inc. 17.96 Million USD 4.966%
Zentalis Pharmaceuticals, Inc. 124.63 Million USD 86.304%
Sagimet Biosciences Inc. 5.65 Million USD -201.91%
MediciNova, Inc. 3.89 Million USD -338.642%
Praxis Precision Medicines, Inc. 18.27 Million USD 6.614%
Cardio Diagnostics Holdings, Inc. 1.5 Million USD -1034.792%
GeoVax Labs, Inc. 3.51 Million USD -384.96%
Axsome Therapeutics, Inc. 397.25 Million USD 95.703%
Biomea Fusion, Inc. 30.69 Million USD 44.379%
PTC Therapeutics, Inc. 2.72 Billion USD 99.373%
Mereo BioPharma Group plc 15.96 Million USD -6.941%
Cullinan Oncology, Inc. 31.2 Million USD 45.29%
Syndax Pharmaceuticals, Inc. 58.68 Million USD 70.912%
Absci Corporation 58.3 Million USD 70.722%
NRx Pharmaceuticals, Inc. 19.04 Million USD 10.384%
4D Molecular Therapeutics, Inc. 32.06 Million USD 46.759%
Dyne Therapeutics, Inc. 73.79 Million USD 76.867%
Kiniksa Pharmaceuticals, Ltd. 87.48 Million USD 80.488%
Ventyx Biosciences, Inc. 33.77 Million USD 49.452%
Allakos Inc. 74.79 Million USD 77.177%
Imunon, Inc. 8.53 Million USD -100.107%
Fulcrum Therapeutics, Inc. 22.5 Million USD 24.137%
Corcept Therapeutics Incorporated 114.81 Million USD 85.132%
BioAtla, Inc. 48.98 Million USD 65.153%
NLS Pharmaceutics AG 10.68 Million USD -59.828%
Bio-Path Holdings, Inc. 2.77 Million USD -514.25%
Allogene Therapeutics, Inc. 130.6 Million USD 86.93%
Larimar Therapeutics, Inc. 14.21 Million USD -20.084%
XOMA Corporation 145.58 Million USD 88.274%
Kezar Life Sciences, Inc. 33.66 Million USD 49.295%
Cara Therapeutics, Inc. 68.75 Million USD 75.174%
aTyr Pharma, Inc. 31.59 Million USD 45.976%
Aligos Therapeutics, Inc. 61.82 Million USD 72.389%
Akero Therapeutics, Inc. 44.96 Million USD 62.037%
Viridian Therapeutics, Inc. 48.4 Million USD 64.733%
Eliem Therapeutics, Inc. 2.87 Million USD -494.774%
EyeGate Pharmaceuticals, Inc. 8.15 Million USD -109.242%
Akari Therapeutics, Plc 4.58 Million USD -272.382%
Tevogen Bio Holdings Inc. 17.73 Million USD 3.739%
Halozyme Therapeutics, Inc. 1.64 Billion USD 98.965%
Lexaria Bioscience Corp. 403.9 Thousand USD -4126.21%
UroGen Pharma Ltd. 243.52 Million USD 92.99%
Sutro Biopharma, Inc. 321.08 Million USD 94.684%
ZIVO Bioscience, Inc. 2.76 Million USD -518.129%
Orgenesis Inc. 35.53 Million USD 51.963%
Entera Bio Ltd. 1.37 Million USD -1137.854%
GH Research PLC 6.7 Million USD -154.738%
Lisata Therapeutics, Inc. 6.8 Million USD -151.029%
Reneo Pharmaceuticals, Inc. 18.82 Million USD 9.328%
Xencor, Inc. 283.55 Million USD 93.98%
60 Degrees Pharmaceuticals, Inc. 2.98 Million USD -471.73%
Replimune Group, Inc. 113.21 Million USD 84.922%
Coeptis Therapeutics Holdings, Inc. 3.75 Million USD -354.337%
Vanda Pharmaceuticals Inc. 103.53 Million USD 83.512%
Lexaria Bioscience Corp. 403.9 Thousand USD -4126.21%
Portage Biotech Inc. 4.45 Million USD -283.596%
Cardio Diagnostics Holdings, Inc. 1.5 Million USD -1034.792%
Olema Pharmaceuticals, Inc. 23.05 Million USD 25.944%
OncoCyte Corporation 49.29 Million USD 65.374%
Qualigen Therapeutics, Inc. 4.13 Million USD -312.637%
Processa Pharmaceuticals, Inc. 797.48 Thousand USD -2040.482%
Purple Biotech Ltd. 10 Million USD -70.615%
CollPlant Biotechnologies Ltd. 5.78 Million USD -195.022%
scPharmaceuticals Inc. 57.26 Million USD 70.189%
ProMIS Neurosciences, Inc. 12.38 Million USD -37.794%
HilleVax, Inc. 78.9 Million USD 78.367%
NeuroSense Therapeutics Ltd. 5.05 Million USD -238.02%
Tharimmune, Inc. 1.81 Million USD -840.472%
Genprex, Inc. 3.25 Million USD -424.552%
Neumora Therapeutics, Inc. Common Stock 27.11 Million USD 37.055%
Atossa Therapeutics, Inc. 5.23 Million USD -226.012%
XTL Biopharmaceuticals Ltd. 206 Thousand USD -8186.408%
Virios Therapeutics, Inc. 358.54 Thousand USD -4660.869%
OKYO Pharma Limited 7.42 Million USD -130.028%
Savara Inc. 37.19 Million USD 54.103%
Curis, Inc. 57.61 Million USD 70.371%
Daré Bioscience, Inc. 26.32 Million USD 35.169%
Carmell Therapeutics Corporation 39.19 Million USD 56.454%
Titan Pharmaceuticals, Inc. 1.44 Million USD -1082.133%
Achieve Life Sciences, Inc. 20.81 Million USD 18.008%
BeiGene, Ltd. 2.23 Billion USD 99.236%
Kiromic BioPharma, Inc. 21.28 Million USD 19.821%
Revolution Medicines, Inc. Warrant 262.39 Million USD 93.495%
Protagonist Therapeutics, Inc. 21.27 Million USD 19.761%
Erasca, Inc. 78.61 Million USD 78.285%
bluebird bio, Inc. 424.62 Million USD 95.98%
Protagenic Therapeutics, Inc. 655.25 Thousand USD -2505.105%
BioMarin Pharmaceutical Inc. 1.89 Billion USD 99.097%
DBV Technologies S.A. 42.8 Million USD 60.117%
Protagenic Therapeutics, Inc. 655.25 Thousand USD -2505.105%
Moderna, Inc. 4.57 Billion USD 99.627%
Vincerx Pharma, Inc. 6.99 Million USD -144.031%
Fresh Tracks Therapeutics, Inc. 1.65 Million USD -930.797%
Molecular Templates, Inc. 31.17 Million USD 45.238%
Travere Therapeutics, Inc. 588.1 Million USD 97.097%
Monte Rosa Therapeutics, Inc. 124.5 Million USD 86.29%
Spruce Biosciences, Inc. 27.43 Million USD 37.785%
Celldex Therapeutics, Inc. 36.45 Million USD 53.176%
Cogent Biosciences, Inc. 55.63 Million USD 69.318%
MacroGenics, Inc. 154.2 Million USD 88.93%
RenovoRx, Inc. 4.46 Million USD -282.221%
Adicet Bio, Inc. 37.12 Million USD 54.014%
Prime Medicine, Inc. 60.78 Million USD 71.915%
Aditxt, Inc. 28.53 Million USD 40.172%
Adagene Inc. 45.16 Million USD 62.209%
Estrella Immunopharma, Inc. 180.7 Thousand USD -9346.544%
Quantum-Si incorporated 26.63 Million USD 35.902%
Maravai LifeSciences Holdings, Inc. 697.56 Million USD 97.553%
Acurx Pharmaceuticals, Inc. 3.04 Million USD -461.063%
Voyager Therapeutics, Inc. 114.96 Million USD 85.151%
SciSparc Ltd. 1.59 Million USD -970.219%
Vericel Corporation 127.7 Million USD 86.633%
Revelation Biosciences, Inc. 5.56 Million USD -206.744%
Minerva Neurosciences, Inc. 85.35 Million USD 80.002%
Generation Bio Co. 171.63 Million USD 90.054%
Astria Therapeutics, Inc. 11.55 Million USD -47.792%
Black Diamond Therapeutics, Inc. 41.83 Million USD 59.193%
Arcutis Biotherapeutics, Inc. 252.69 Million USD 93.245%
Invivyd, Inc. 51.71 Million USD 66.991%
Relay Therapeutics, Inc. 91.97 Million USD 81.441%
Quoin Pharmaceuticals, Ltd. 6.5 Million USD -162.403%
Spero Therapeutics, Inc. 75.49 Million USD 77.39%
Artelo Biosciences, Inc. 1.02 Million USD -1571.89%
2seventy bio, Inc. 310.12 Million USD 94.496%
ADMA Biologics, Inc. 193.97 Million USD 91.2%
Clene Inc. 38.95 Million USD 56.176%
Capricor Therapeutics, Inc. 36.13 Million USD 52.758%
Boundless Bio, Inc. Common Stock 256.97 Million USD 93.357%
GeoVax Labs, Inc. 3.51 Million USD -384.96%
Recursion Pharmaceuticals, Inc. 190.26 Million USD 91.028%
Citius Pharmaceuticals, Inc. 12.17 Million USD -40.152%
Contineum Therapeutics, Inc. Class A Common Stock 198.32 Million USD 91.393%
Relmada Therapeutics, Inc. 12.19 Million USD -39.978%
Finch Therapeutics Group, Inc. 48.11 Million USD 64.52%
ALX Oncology Holdings Inc. 52.84 Million USD 67.696%
Vir Biotechnology, Inc. 369.85 Million USD 95.385%
Evaxion Biotech A/S 17.61 Million USD 3.108%
Ocular Therapeutix, Inc. 160.92 Million USD 89.393%
Verve Therapeutics, Inc. 153.18 Million USD 88.857%
Trevena, Inc. 48.26 Million USD 64.631%
Surrozen, Inc. 8.14 Million USD -109.576%
Tyra Biosciences, Inc. 21.59 Million USD 20.954%
Cingulate Inc. 10.36 Million USD -64.755%
Galmed Pharmaceuticals Ltd. 2.75 Million USD -520.727%
Unity Biotechnology, Inc. 37.29 Million USD 54.226%
Tenax Therapeutics, Inc. 3.58 Million USD -375.949%
Terns Pharmaceuticals, Inc. 13.15 Million USD -29.81%
ACADIA Pharmaceuticals Inc. 317.2 Million USD 94.619%
Connect Biopharma Holdings Limited 24.84 Million USD 31.305%
Clearmind Medicine Inc. 3.61 Million USD -372.852%
Kronos Bio, Inc. 54.2 Million USD 68.506%
Bolt Biotherapeutics, Inc. 47.04 Million USD 63.714%
CERo Therapeutics Holdings, Inc. 22.75 Million USD 24.999%
Viking Therapeutics, Inc. 20.07 Million USD 14.952%
Statera Biopharma, Inc. 22.67 Million USD 24.724%
ImmunityBio, Inc. 1.09 Billion USD 98.435%
Korro Bio, Inc. 51.75 Million USD 67.016%
Kineta, Inc. 7.22 Million USD -136.361%
BioVie Inc. 9.7 Million USD -75.941%
Codexis, Inc. 49.94 Million USD 65.823%
Celularity Inc. 102.92 Million USD 83.416%
Crinetics Pharmaceuticals, Inc. 96.24 Million USD 82.264%
Celcuity Inc. 51.45 Million USD 66.822%
Virax Biolabs Group Limited 345.19 Thousand USD -4845.045%
Cibus, Inc. 206.11 Million USD 91.718%
Eledon Pharmaceuticals, Inc. 42.47 Million USD 59.812%
eFFECTOR Therapeutics, Inc. 26.33 Million USD 35.191%
IN8bio, Inc. 8.77 Million USD -94.596%
Kodiak Sciences Inc. 213.59 Million USD 92.008%
Annexon, Inc. 47.11 Million USD 63.772%
Adverum Biotechnologies, Inc. 89.54 Million USD 80.936%
Assembly Biosciences, Inc. 96.37 Million USD 82.287%
Avalo Therapeutics, Inc. 13.68 Million USD -24.699%
Ionis Pharmaceuticals, Inc. 2.6 Billion USD 99.344%
Eyenovia, Inc. 19.78 Million USD 13.702%
Puma Biotechnology, Inc. 177.08 Million USD 90.361%
Conduit Pharmaceuticals Inc. 7.68 Million USD -122.237%
Xilio Therapeutics, Inc. 24.09 Million USD 29.167%
Arcellx, Inc. 339.75 Million USD 94.976%
Cardiff Oncology, Inc. 11.89 Million USD -43.469%
Enanta Pharmaceuticals, Inc. 245.54 Million USD 93.048%
Regulus Therapeutics Inc. 9.56 Million USD -78.5%
Moolec Science SA 13.94 Million USD -22.406%
Acumen Pharmaceuticals, Inc. 43.15 Million USD 60.442%
Geron Corporation 146.12 Million USD 88.318%
LAVA Therapeutics N.V. 50.53 Million USD 66.219%
Royalty Pharma plc 6.29 Billion USD 99.729%
Atea Pharmaceuticals, Inc. 39.77 Million USD 57.085%
Greenwich LifeSciences, Inc. 294.4 Thousand USD -5698.116%
TFF Pharmaceuticals, Inc. 2.46 Million USD -593.823%
Mersana Therapeutics, Inc. 189.15 Million USD 90.976%
Humacyte, Inc. 114.67 Million USD 85.115%
Structure Therapeutics Inc. 29.05 Million USD 41.241%
89bio, Inc. 59.96 Million USD 71.532%
PMV Pharmaceuticals, Inc. 26.46 Million USD 35.495%
Avenue Therapeutics, Inc. 1.19 Million USD -1327.258%
Genelux Corporation 8.42 Million USD -102.732%
Trevi Therapeutics, Inc. 6.85 Million USD -148.979%
Lexicon Pharmaceuticals, Inc. 136.31 Million USD 87.478%
Notable Labs, Ltd. 4.42 Million USD -285.588%
Liquidia Corporation 73.13 Million USD 76.661%
Mustang Bio, Inc. 17.61 Million USD 3.116%
Immunovant, Inc. 48.95 Million USD 65.131%
Quantum-Si incorporated 26.63 Million USD 35.902%
Arbutus Biopharma Corporation 38.38 Million USD 55.527%
DiaMedica Therapeutics Inc. 3.1 Million USD -450.113%
Vera Therapeutics, Inc. 73.86 Million USD 76.889%
Acasti Pharma Inc. 11.55 Million USD -47.703%
MiNK Therapeutics, Inc. 22.6 Million USD 24.495%
Pasithea Therapeutics Corp. 2.71 Million USD -527.942%
Xenon Pharmaceuticals Inc. 36.87 Million USD 53.711%
Elevai Labs, Inc. Common Stock 1.36 Million USD -1152.53%
NeuroBo Pharmaceuticals, Inc. 6.09 Million USD -180.02%
Tempest Therapeutics, Inc. 24.83 Million USD 31.266%
Soleno Therapeutics, Inc. 23.18 Million USD 26.372%
PepGen Inc. 34.63 Million USD 50.709%
Moleculin Biotech, Inc. 12.14 Million USD -40.563%
United Therapeutics Corporation 1.18 Billion USD 98.556%
Nuvectis Pharma, Inc. 6.98 Million USD -144.416%
Solid Biosciences Inc. 38.45 Million USD 55.614%
BriaCell Therapeutics Corp. 8.55 Million USD -99.481%
Immuneering Corporation 12 Million USD -42.151%
Lixte Biotechnology Holdings, Inc. 313.85 Thousand USD -5338.765%
Silo Pharma, Inc. 1.56 Million USD -987.767%
Belite Bio, Inc 4.21 Million USD -305.367%
XOMA Corporation 145.58 Million USD 88.274%
ARS Pharmaceuticals, Inc. 2.42 Million USD -603.048%
Bionomics Limited 10.15 Million USD -68.033%
Apogee Therapeutics, Inc. 21.49 Million USD 20.571%
Alpha Tau Medical Ltd. 22.91 Million USD 25.501%
uniQure N.V. 624.01 Million USD 97.265%
Cassava Sciences, Inc. 14.19 Million USD -20.254%
Estrella Immunopharma, Inc. 180.7 Thousand USD -9346.544%
Poseida Therapeutics, Inc. 170.18 Million USD 89.97%
Forte Biosciences, Inc. 3.66 Million USD -365.63%
Anebulo Pharmaceuticals, Inc. 260.58 Thousand USD -6450.696%
Enlivex Therapeutics Ltd. 6.74 Million USD -153.001%
Conduit Pharmaceuticals Inc. 7.68 Million USD -122.237%
SeaStar Medical Holding Corporation 17.38 Million USD 1.801%
FibroBiologics, Inc. Common Stock 10.56 Million USD -61.525%
Altimmune, Inc. 16.54 Million USD -3.198%
Amicus Therapeutics, Inc. 617.7 Million USD 97.237%
Alpha Tau Medical Ltd. 22.91 Million USD 25.501%
Compugen Ltd. 55.77 Million USD 69.395%
Peak Bio, Inc. 20.75 Million USD 17.748%
Zevra Therapeutics, Inc. 110.46 Million USD 84.547%
Benitec Biopharma Inc. 4.96 Million USD -244.015%
Spyre Therapeutics, Inc. 157.84 Million USD 89.185%
NKGen Biotech, Inc. Common Stock 75.17 Million USD 77.293%
Zura Bio Limited 21.29 Million USD 19.829%
PolyPid Ltd. 17.46 Million USD 2.278%
Aileron Therapeutics, Inc. 112.39 Million USD 84.813%
NKGen Biotech, Inc. Warrants 75.17 Million USD 77.293%
Instil Bio, Inc. 99.8 Million USD 82.896%
argenx SE 444.95 Million USD 96.164%
Immunome, Inc. 28.65 Million USD 40.435%
Compass Therapeutics, Inc. 8.33 Million USD -104.75%
Verona Pharma plc 58.84 Million USD 70.99%
enGene Holdings Inc. Warrants 14.47 Million USD -17.944%
Shattuck Labs, Inc. 14.85 Million USD -14.88%
CervoMed Inc. 2.59 Million USD -557.614%
LENZ Therapeutics, Inc. 4.87 Million USD -250.226%
Plus Therapeutics, Inc. 12.73 Million USD -34.03%
Dianthus Therapeutics, Inc. 10.53 Million USD -62.031%
Moolec Science SA 13.94 Million USD -22.406%
Enveric Biosciences, Inc. 2.34 Million USD -628.396%
Inovio Pharmaceuticals, Inc. 55.59 Million USD 69.296%
AnaptysBio, Inc. 364.28 Million USD 95.314%
Design Therapeutics, Inc. 11.95 Million USD -42.774%
Leap Therapeutics, Inc. 12.68 Million USD -34.579%
NeurAxis, Inc. 1.91 Million USD -792.437%
Seelos Therapeutics, Inc. 38.92 Million USD 56.15%
Lumos Pharma, Inc. 13.33 Million USD -28.028%
Achilles Therapeutics plc 19.08 Million USD 10.567%
enGene Holdings Inc. Common Stock 14.47 Million USD -17.944%
180 Life Sciences Corp. 5.38 Million USD -216.862%
Opiant Pharmaceuticals, Inc. 23.58 Million USD 27.633%
CERo Therapeutics Holdings, Inc. 22.75 Million USD 24.999%
Nutriband Inc. 1.07 Million USD -1482.139%
ORIC Pharmaceuticals, Inc. 30.59 Million USD 44.212%
CG Oncology, Inc. Common stock 14.51 Million USD -17.635%
Fractyl Health, Inc. Common Stock 401.27 Million USD 95.746%
Rani Therapeutics Holdings, Inc. 32.47 Million USD 47.433%
MoonLake Immunotherapeutics 13.04 Million USD -30.814%
Palisade Bio, Inc. 2.73 Million USD -523.22%
Tourmaline Bio, Inc. 5.25 Million USD -224.957%
Beam Therapeutics Inc. 478.38 Million USD 96.432%
Neurogene Inc. 36.54 Million USD 53.296%
Mirum Pharmaceuticals, Inc. 397.95 Million USD 95.711%
AEON Biopharma, Inc. 159.88 Million USD 89.324%
CARGO Therapeutics, Inc. Common Stock 47.65 Million USD 64.176%
Sesen Bio, Inc. 30.98 Million USD 44.907%
Enliven Therapeutics, Inc. 25.96 Million USD 34.248%
Kiora Pharmaceuticals, Inc. 7.6 Million USD -124.54%
Iovance Biotherapeutics, Inc. 195.73 Million USD 91.279%
Taysha Gene Therapies, Inc. 192.05 Million USD 91.112%
Athira Pharma, Inc. 30.05 Million USD 43.208%
Vaccinex, Inc. 5.94 Million USD -187.277%
HCW Biologics Inc. 15.05 Million USD -13.407%
XOMA Corporation 145.58 Million USD 88.274%
Nektar Therapeutics 267.04 Million USD 93.608%
Arvinas, Inc. 644.6 Million USD 97.352%
Tevogen Bio Holdings Inc. 17.73 Million USD 3.739%
Merus N.V. 102.15 Million USD 83.289%
Omega Therapeutics, Inc. 146.35 Million USD 88.336%
Quince Therapeutics, Inc. 95.12 Million USD 82.054%
Rezolute, Inc. 11.73 Million USD -45.475%
Clene Inc. 38.95 Million USD 56.176%
Indaptus Therapeutics, Inc. 2.84 Million USD -499.498%
BeyondSpring Inc. 48.26 Million USD 64.636%
Synlogic, Inc. 32.89 Million USD 48.108%
Allarity Therapeutics, Inc. 14.61 Million USD -16.814%
Phio Pharmaceuticals Corp. 1.63 Million USD -944.676%
Peak Bio, Inc. 20.75 Million USD 17.748%
Werewolf Therapeutics, Inc. 63.45 Million USD 73.101%
Krystal Biotech, Inc. 39.71 Million USD 57.018%
Karyopharm Therapeutics Inc. 376.64 Million USD 95.468%
SpringWorks Therapeutics, Inc. 99.56 Million USD 82.856%
Lipella Pharmaceuticals Inc. 432.72 Thousand USD -3844.76%
MannKind Corporation 721.36 Million USD 97.634%
Ikena Oncology, Inc. 22.33 Million USD 23.573%
Cyclerion Therapeutics, Inc. 2.08 Million USD -718.313%
Gyre Therapeutics, Inc. 102.59 Million USD 83.361%
Gossamer Bio, Inc. 249.14 Million USD 93.149%
CohBar, Inc. 1.03 Million USD -1551.449%
Cognition Therapeutics, Inc. 10.68 Million USD -59.697%
NRx Pharmaceuticals, Inc. 19.04 Million USD 10.384%
Legend Biotech Corporation 589.93 Million USD 97.106%
Mural Oncology plc 37.92 Million USD 54.994%
Biora Therapeutics, Inc. 132.63 Million USD 87.13%
PaxMedica, Inc. Common Stock 2.29 Million USD -643.683%
Disc Medicine, Inc. 22.87 Million USD 25.377%
Champions Oncology, Inc. 28.03 Million USD 39.112%
REGENXBIO Inc. 262.22 Million USD 93.49%
Ensysce Biosciences, Inc. 3.35 Million USD -408.134%
Anavex Life Sciences Corp. 12.53 Million USD -36.19%
Cellectar Biosciences, Inc. 13.43 Million USD -27.088%
Edgewise Therapeutics, Inc. 21.2 Million USD 19.5%
Vaxart, Inc. 34.02 Million USD 49.831%
PharmaCyte Biotech, Inc. 20.38 Million USD 16.279%
Aldeyra Therapeutics, Inc. 28.53 Million USD 40.172%
Cellectis S.A. 249.57 Million USD 93.16%
Longeveron Inc. 5.33 Million USD -219.843%
Repare Therapeutics Inc. 41.81 Million USD 59.181%
Sarepta Therapeutics, Inc. 2.4 Billion USD 99.29%
Inozyme Pharma, Inc. 60.36 Million USD 71.723%
Revolution Medicines, Inc. 262.39 Million USD 93.495%
Nymox Pharmaceutical Corporation 2.1 Million USD -710.157%
Third Harmonic Bio, Inc. 8.62 Million USD -97.89%
ArriVent BioPharma, Inc. Common Stock 11.8 Million USD -44.649%
AN2 Therapeutics, Inc. 14.04 Million USD -21.555%
Anixa Biosciences, Inc. 2.15 Million USD -693.584%
Vertex Pharmaceuticals Incorporated 5.14 Billion USD 99.669%
Denali Therapeutics Inc. 122.96 Million USD 86.118%
Revelation Biosciences, Inc. 5.56 Million USD -206.744%
Veru Inc. 32.81 Million USD 47.977%
Corvus Pharmaceuticals, Inc. 6.86 Million USD -148.508%
Cingulate Inc. 10.36 Million USD -64.755%
Passage Bio, Inc. 39.26 Million USD 56.523%
Context Therapeutics Inc. 4.19 Million USD -307.232%
Exicure, Inc. 8.54 Million USD -99.672%
Day One Biopharmaceuticals, Inc. 29.5 Million USD 42.151%
Oramed Pharmaceuticals Inc. 10.48 Million USD -62.788%
Scinai Immunotherapeutics Ltd. 22.04 Million USD 22.553%
Rhythm Pharmaceuticals, Inc. 162.98 Million USD 89.527%
Nuvalent, Inc. 31.82 Million USD 46.36%
ABVC BioPharma, Inc. 6.36 Million USD -168.328%
Carisma Therapeutics, Inc. 63.02 Million USD 72.914%
Unicycive Therapeutics, Inc. 18 Million USD 5.167%
OmniAb, Inc. 87.4 Million USD 80.469%
Anew Medical, Inc. 8.24 Million USD -107.115%
Fennec Pharmaceuticals Inc. 38.28 Million USD 55.418%
Lipocine Inc. 2.63 Million USD -548.648%
Lexeo Therapeutics, Inc. Common Stock 26.27 Million USD 35.026%
Nautilus Biotechnology, Inc. 40.21 Million USD 57.55%
SAB Biotherapeutics, Inc. 26.64 Million USD 35.928%
G1 Therapeutics, Inc. 86.15 Million USD 80.187%
Bellerophon Therapeutics, Inc. 5.4 Million USD -216.053%
Sage Therapeutics, Inc. 82.74 Million USD 79.371%
Ocugen, Inc. 23.98 Million USD 28.825%
Mind Medicine (MindMed) Inc. 46.4 Million USD 63.217%
Q32 Bio Inc. 233.12 Million USD 92.678%
Brainstorm Cell Therapeutics Inc. 9.06 Million USD -88.286%
Alumis Inc. Common Stock 53.5 Million USD 68.095%
Equillium, Inc. 27.95 Million USD 38.942%
Kyverna Therapeutics, Inc. 206.59 Million USD 91.737%
Coya Therapeutics, Inc. 5.62 Million USD -203.377%
CNS Pharmaceuticals, Inc. 6.13 Million USD -178.332%
Galera Therapeutics, Inc. 157.32 Million USD 89.15%
Evelo Biosciences, Inc. 69.43 Million USD 75.415%
Comera Life Sciences Holdings, Inc. 9.97 Million USD -71.142%
Dominari Holdings Inc. 4.63 Million USD -268.285%
Edesa Biotech, Inc. 1.84 Million USD -826.893%
vTv Therapeutics Inc. 29.56 Million USD 42.267%
Bio-Techne Corporation 744.34 Million USD 97.707%
Agios Pharmaceuticals, Inc. 126.09 Million USD 86.463%
Harmony Biosciences Holdings, Inc. 344.45 Million USD 95.044%
Prelude Therapeutics Incorporated 40.57 Million USD 57.93%
Candel Therapeutics, Inc. 28.95 Million USD 41.051%
iTeos Therapeutics, Inc. 92.36 Million USD 81.518%
Nkarta, Inc. 105.6 Million USD 83.835%
BioCardia, Inc. 4.59 Million USD -271.895%
Iterum Therapeutics plc 32.66 Million USD 47.737%